1. Home
  2. XENE vs AMBA Comparison

XENE vs AMBA Comparison

Compare XENE & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • AMBA
  • Stock Information
  • Founded
  • XENE 1996
  • AMBA 2004
  • Country
  • XENE Canada
  • AMBA United States
  • Employees
  • XENE N/A
  • AMBA N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • AMBA Semiconductors
  • Sector
  • XENE Health Care
  • AMBA Technology
  • Exchange
  • XENE Nasdaq
  • AMBA Nasdaq
  • Market Cap
  • XENE 3.2B
  • AMBA 3.5B
  • IPO Year
  • XENE 2014
  • AMBA N/A
  • Fundamental
  • Price
  • XENE $43.87
  • AMBA $90.26
  • Analyst Decision
  • XENE Strong Buy
  • AMBA Strong Buy
  • Analyst Count
  • XENE 11
  • AMBA 10
  • Target Price
  • XENE $53.55
  • AMBA $93.44
  • AVG Volume (30 Days)
  • XENE 782.5K
  • AMBA 802.0K
  • Earning Date
  • XENE 11-03-2025
  • AMBA 11-25-2025
  • Dividend Yield
  • XENE N/A
  • AMBA N/A
  • EPS Growth
  • XENE N/A
  • AMBA N/A
  • EPS
  • XENE N/A
  • AMBA N/A
  • Revenue
  • XENE $7,500,000.00
  • AMBA $348,051,000.00
  • Revenue This Year
  • XENE N/A
  • AMBA $35.94
  • Revenue Next Year
  • XENE $207.88
  • AMBA $8.00
  • P/E Ratio
  • XENE N/A
  • AMBA N/A
  • Revenue Growth
  • XENE N/A
  • AMBA 57.91
  • 52 Week Low
  • XENE $26.74
  • AMBA $38.86
  • 52 Week High
  • XENE $44.23
  • AMBA $96.69
  • Technical
  • Relative Strength Index (RSI)
  • XENE 68.37
  • AMBA 55.81
  • Support Level
  • XENE $39.09
  • AMBA $80.31
  • Resistance Level
  • XENE $42.31
  • AMBA $92.79
  • Average True Range (ATR)
  • XENE 1.48
  • AMBA 5.76
  • MACD
  • XENE 0.31
  • AMBA -0.20
  • Stochastic Oscillator
  • XENE 99.40
  • AMBA 63.00

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

Share on Social Networks: